Formulation and Evaluation of Nateglinide Sustained Release Tablets

Formulation and Evaluation of Sustained Release Matrix Tablets of Glipizide

      The purpose of this study was to develop a new monolithic matrix tablet to completely deliver glipizide in a zero order manner over a sustained period. Two approaches were examined using drug in a formulation that contain polymer like hydroxylpropyl methyl-cellulose K 100 (HPMCK) and Eudragit L 100. The granules were prepared by wet granulation method and thereby formulated as F-1, F-2. F...

formulation and evaluation of sustained release matrix tablets of glipizide

the purpose of this study was to develop a new monolithic matrix tablet to completely deliver glipizide in a zero order manner over a sustained period. two approaches were examined using drug in a formulation that contain polymer like hydroxylpropyl methyl-cellulose k 100 (hpmck) and eudragit l 100. the granules were prepared by wet granulation method and thereby formulated as f-1, f-2. f-3 and...

Formulation and Evaluation of Sustained Release Tablets Using Prunus armeniaca (L.) and Prunus domestica (L.) Gums

Formulation and Evaluation of Sustained Release Matrix Tablets of Ranolazine

The aim of the present study was to prepare and characterize the Sustained release matrix tablets of Ranolazine using Kollidon® SR. Kollidon® SR is a polyvinyl acetate based excipient. Three different strengths i.e 375mg, 500mg and 750mg of ranolazine SR tablets were prepared by direct compression method and by using common blend. The influence of compression force was studied on the dissolutio...

Formulation and Evaluation of Sustained Release Tablets of Chlorzoxazone

Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain and discomfort which are having shorter half life (1.1hour) with the dose administration of 3-4 times a day. The aim of the study was to prepare and evaluate the Chlorzoxazone sustained release tablets in order to reduce the dose frequency and to improve the patient compliance. The tablets were...